HIGHLIGHTS
The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of theSECuRE trial has been treated with their first dose of 8 GBq of 67Cu-SAR-bisPSMA.This follows the re
SUZHOU,China,April 15,2025-- In January 2025 (U.S. time),the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted by XellSmart Biopharma
FAIRFAX,Va.,April 16,2025-- The Stevie® Awards,organizer of the world\'s premier business awards programs,announced the winners of five Grand Stevie® Award trophies in the 12th annual Asia-Pac
Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing,robotic organ transplantation,precision drug delivery,and novel pain treatments
HO CHI MINH CITY,Vietnam,April 17,2025-- Amid Southeast Asia\'s fast-evolving real estate and hospitality landscape,industry leaders are coming together in Bangkok for an evening that blends insight,s
LONDON,April 17,2025-- Rio Tinto and AMG Metals & Materials (AMG M&M),an energy transition solutions provider,have signed a Memorandum of Understanding (MOU) to jointly assess the feasibility